J. Goldman & CO LP Olema Pharmaceuticals, Inc. Transaction History
J. Goldman & CO LP
- $3.8 Billion
- Q1 2025
A detailed history of J. Goldman & CO LP transactions in Olema Pharmaceuticals, Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 13,500 shares of OLMA stock, worth $71,685. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,500
Previous 13,500
-0.0%
Holding current value
$71,685
Previous $78,000
35.9%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding OLMA
# of Institutions
135Shares Held
64.6MCall Options Held
6.3KPut Options Held
15.2K-
Bain Capital Life Sciences Investors, LLC Boston, MA6.84MShares$36.3 Million8.64% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY6.74MShares$35.8 Million1.3% of portfolio
-
Bvf Inc San Francisco, CA5.3MShares$28.1 Million0.88% of portfolio
-
Black Rock Inc. New York, NY4MShares$21.2 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.44MShares$18.3 Million0.45% of portfolio
About Olema Pharmaceuticals, Inc.
- Ticker OLMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,419,600
- Market Cap $215M
- Description
- Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...